Amen to that. It's boggling (O_o)
Yet, the ASX biotech sector did rise 50% last year. So there's that.
Recently, PAB Announced milestone achievement of orphan drug status, and PAB went up.
The successful phase 1/2a clinical trial, 10year followup, 2014 licensing objectives, solid cash position, etc, etc, etc left the market nonplussed as Biotech globally went down.
Profiteering reigns and PAB was swept along for the ride (past six weeks downwards trend in the US).
The current biotech fall appears to be concerned with over-valuations, comfortingly, PAB would not appear to be such. Once the market re-evaluates, PAB should be sitting pretty. If anyone has access to an external asset audit of PAB, that'd be great. Should assist the shareprice too, science talent/equipment/network don't come cheap.
While there are serious concerns for the global economy in general, there is opportunity in a crisis. Especially when the greed kicks back in and an upward tick is clear.
Amen to that. It's boggling (O_o)Yet, the ASX biotech sector did...
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $43.28K | 6.183M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 237374 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1732079 | 8 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| PAB (ASX) Chart |